uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Income towards Parent Company (2016 - 2026)

uniQure (QURE) posted quarterly Income towards Parent Company of -$81.1 million for Q2 2026, down 114.9% year-over-year from $543.9 million in Q2 2025, and down 51.41% quarter-over-quarter from -$53.5 million in Q1 2026.

Analysis

uniQure (QURE) Income towards Parent Company (2016 - 2026) Analysis & Trends

uniQure's Income towards Parent Company history runs 11 years deep, the most recent figure standing at -$81.1 million for Q2 2026.

  • In Q2 2026, Income towards Parent Company fell 114.9% year-over-year to -$81.1 million; the TTM figure through Jun 2026 stood at -$196.7 million (down 45.16% YoY), while the FY2025 annual figure was -$143.5 million, up 18.47% from the prior year.
  • Income towards Parent Company for Q2 2026 stood at -$81.1 million, down from -$53.5 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $38.4 million in Q4 2022, with the low at -$89.6 million in Q3 2023.
  • The 5-year median for Income towards Parent Company is -$47.3 million (2022), against an average of -$43.2 million.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company plunged 223.65% in 2024, then soared 290.89% in 2025.
  • uniQure's Income towards Parent Company stood at $38.4 million in 2022, then sank by 79.68% to $7.8 million in 2023, then slumped by 223.65% to -$9.7 million in 2024, then jumped by 290.89% to $18.4 million in 2025, then sank by 539.89% to -$81.1 million in 2026.
  • Business Quant data shows QURE's Income towards Parent Company at -$81.1 million in Q2 2026, -$53.5 million in Q1 2026, and $18.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.06 Mn
Mar 31, 2026 -53.54 Mn
Dec 31, 2025 18.43 Mn
Sep 30, 2025 -80.53 Mn
Jun 30, 2025 -37.72 Mn
Mar 31, 2025 -43.64 Mn
Dec 31, 2024 -9.65 Mn
Sep 30, 2024 -44.50 Mn
Jun 30, 2024 -56.30 Mn
Mar 31, 2024 -65.62 Mn
Dec 31, 2023 7.81 Mn
Sep 30, 2023 -89.57 Mn
Jun 30, 2023 -68.47 Mn
Mar 31, 2023 -77.23 Mn
Dec 31, 2022 38.43 Mn
Sep 30, 2022 -47.86 Mn
Jun 30, 2022 -39.06 Mn
Mar 31, 2022 -46.68 Mn
Dec 31, 2021 -71.78 Mn
Sep 30, 2021 -36.53 Mn